Dr. Awada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3031 W Grand Blvd
Detroit, MI 48202Phone+1 313-916-2464
Education & Training
George Washington UniversityResidency, Obstetrics and Gynecology, 2010 - 2014
American University of Beirut Faculty of MedicineClass of 2009
Certifications & Licensure
MI State Medical License 2024 - 2027
FL State Medical License 2021 - 2025
NY State Medical License 2018 - 2021
PA State Medical License 2014 - 2021
VA State Medical License 2010 - 2014
DC State Medical License 2010 - 2012- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Clinical Trials
- EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients Start of enrollment: 2007 Jan 01
- Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx Start of enrollment: 2007 May 01
- A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour Start of enrollment: 2008 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Therapeutic Prospects of Abemaciclib for Patients with Endometrial Cancer.Ahmad Awada, Sarfraz Ahmad
Current Oncology. 2024-09-12 - Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer.Theresa M Kuhn, Sarfraz Ahmad, Fernando O Recio, Ahmad Awada, Nathalie D McKenzie
International Journal of Gynecological Cancer. 2024-07-01 - Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial Cancer.Kyukwang Kim, Negar Khazan, Rachael B Rowswell-Turner, Rakesh K Singh, Taylor Moore
Cancers. 2024-02-28
Press Mentions
PharmaMar Announces Data Presentations for Both Its Molecules Yondelis® and Lurbinectedin at ASCO 2018August 3rd, 2018
‘Fighting My Cancer as Much as Possible’: Why Many Patients Join Phase 1 Clinical TrialsMarch 8th, 2018
Neratinib plus Paclitaxel vs. Trastuzumab plus Paclitaxel in Breast CancerApril 14th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
